Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-042726

Chief Scientific Officer sold 32,146 shares at $8.76 ($281,673)

  • Chief Scientific Officer acquired 18,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2025-03-18 Option exercise 10b5-1 +18,000 $1.55 $27,900 128,673 D: show line 1 in the form
Barone Francesca Chief Scientific Officer 2025-03-18 Sale 10b5-1 −32,146 $8.76 $281,673 96,527 D: show line 2 in the form
Open-market sales · 32,146 sh · avg $8.76 · $281,673

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Barone Francesca Chief Scientific Officer 2025-03-18 Option exercise · Stock Option (Right to Buy) 10b5-1 −18,000 30,822 D: show line 3 in the form
Loading xslF345X05/ownership.xml…